# UNITED STATESSECURITIES AND
EXCHANGE COMMISSIONWASHINGTON, D.C. 20549

---

# FORM 8-K

---

# CURRENT REPORT

# PURSUANT TO SECTION 13
OR 15(d) OFTHE SECURITIES
EXCHANGE ACT OF 1934

Date of Report:
October 25, 2005 (date of earliest event
reported)

---

VASCULAR SOLUTIONS,
INC. (Exact name of
registrant as specified in its charter)

Commission File Number:
0-27605

|Minnesota                                      | 41-1859679                       
|---------------------------------------------- | ---------------------------------
|(State or other jurisdiction of incorporation) | (IRS Employer Identification No.)

6464 Sycamore CourtMinneapolis, Minnesota
55369(Address of principal
executive offices)

(763) 656-4300 (Registrants
telephone number, including area code)

Not Applicable (Former name or former
address, if changed since last report)

---

Check the appropriate box below if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:

|o |  | Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425)
|- |  | ---------------------------------------------------------------------------------

|o |  | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|- |  | --------------------------------------------------------------------------------------

|o |  | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|- |  | ------------------------------------------------------------------------------------------------------

|o |  | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ( 17 CFR
240.13e-4(c))
|- |  | -------------------------------------------------------------------------------------------------------





---

# Item 2.02. Results of
Operations and Financial Condition

The
following information is being furnished in accordance with Item 2.02 of Form
8-K and shall not be deemed filed for purposes of Section 18 of the Exchange
Act, or otherwise subject to the liabilities of that section, nor shall it be deemed to be
incorporated by reference in any filing under the Securities Act of 1933, as amended, or
the Exchange Act, except as expressly set forth by specific reference in such filing:

| | On
October 25, 2005, Vascular Solutions, Inc. issued a press release to report the
Companys results of operations and financial condition for the completed fiscal
quarter ended September 30, 2005. The release is furnished as Exhibit 99.1 hereto and is
incorporated herein by reference.
| | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

# Item 9.01. Financial
Statements and Exhibits

(c)
          The following exhibit is being furnished in accordance with Item
          2.02 of Form 8-K and shall not be deemed filed for purposes of
          Section 18 of the Securities Exchange Act of 1934, as amended (the
          Exchange Act), or otherwise subject to the liabilities of that
          section, nor shall it be deemed to be incorporated by reference in any filing
          under the Securities Act of 1933, as amended, or the Exchange Act, except as
          expressly set forth by specific reference in such filing:

99.1   Press Release, dated October
25, 2005, of Vascular Solutions, Inc.

# SIGNATURE

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.

|                        | VASCULAR SOLUTIONS, INC. |                                    
|----------------------- | ------------------------ | -----------------------------------
|                       
|Date:  October 25, 2005 | By:                      | /s/ James Hennen                   
|                        |                          | James HennenChief Financial Officer

---

# EXHIBIT INDEX

|Exhibit No. | Description                                                      
|----------- | -----------------------------------------------------------------
|99.1        | Press Release dated October 25, 2005, of Vascular Solutions, Inc.

---